Effects of the proapoptotic regulator Bcl‑2/adenovirus EIB 19‑kDa‑interacting protein 3 on the chemosensitivity of human colon cancer cell lines

A JemalF BrayMM CenterJ FerlayE WardD FormanGlobal cancer statisticsCA Cancer J Clin616990201110.3322/caac.20107

NH SegalLB SaltzEvolving treatment of advanced colon cancerAnnu Rev Med60207219200910.1146/annurev.med.60.041807.132435

C TournigandT AndréE AchilleG LledoM FleshD Mery-MignardE QuinauxC CouteauM BuyseG GanemB LandiP ColinC LouvetA de GramontFOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR studyJ Clin Oncol22229237200410.1200/JCO.2004.05.113

DL WuF HuangHZ LuDrug-resistant proteins in breast cancer: recent progress in multidrug resistanceChin J Cancer22441444200312704006

C Vande VeldeJ CizeauD DubikJ AlimontiT BrownS IsraelsR HakemAH GreenbergBNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition poreMol Cell Biol2054545468200010891486

M MuraiM ToyotaH SuzukiA SatohY SasakiK AkinoM UenoF TakahashiM KusanoH MitaK YanagiharaT EndoY HinodaT TokinoK ImaiAberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancerClin Cancer Res1110211027200515709167

M MuraiM ToyotaA SatohH SuzukiK AkinoH MitaY SasakiT IshidaL ShenG Garcia-ManeroJP IssaY HinodaT TokinoK ImaiAberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumoursBr J Cancer9211651172200510.1038/sj.bjc.660242215756280

J OkamiDM SimeoneCD LogsdonSilencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancerCancer Res6453385346200410.1158/0008-5472.CAN-04-008915289340

Z WangCM HuangQ DengH ZengX WangS ZhangF BiQL TangRM ZhongAJ LiYB HeN ChenZP LiW WangEffects of the proapoptotic regulator Bcl2/adenovirus EIB 19 kDa-interacting protein 3 on radiosensitivity of cervical cancerCancer Biother Radiopharm26279286201110.1089/cbr.2010.089821711117

M AkadaT Crnogorac-JurcevicS LattimoreP MahonR LopesM SunamuraS MatsunoNR LemoineIntrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancerClin Cancer Res1130943101200510.1158/1078-0432.CCR-04-178515837765

M ErkanJ KleeffI EspositoT GieseK KettererMW BüchlerNA GieseH FriessLoss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosisOncogene2444214432200510.1038/sj.onc.120864215856026

H TangYJ LiuM LiuX LiEstablishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHPAnticancer Drugs18633639200710.1097/CAD.0b013e328020042817762391

BC ValdezD MurrayL RamdasM de LimaR JonesS KornblauD BetancourtY LiRE ChamplinBS AnderssonAltered gene expression in busulfan-resistant human myeloid leukemiaLeukemia Research3216841697200810.1016/j.leukres.2008.01.01618339423

M IshiguroS IidaH UetakeS MoritaH MakinoK KatoY TakagiM EnomotoK SugiharaEffect of combined therapy with low-dose 5-Aza-2′-deoxycytidine and irinotecan on colon cancer cell line HCT-15Ann Surg Oncol14175217622007

B DesoizeC MadouletParticular aspects of platinum compounds used at present in cancer treatmentCrit Rev Oncol Hematol42317325200210.1016/S1040-8428(01)00219-012050023

CC ChenLT ChenTC TsouWY PanCC KuoJF LiuSC YehFY TsaiHP HsiehJY ChangCombined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracilBr J Cancer97334344200510.1038/sj.bjc.660386617609664

N MitsiadesWH YuV PoulakiM TsokosI StamenkovicMatrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicityCancer Res61577581200111212252

YG AssarafL RothemJH HooijbergM StarkI IferganI KathmannBA DijkmansGJ PetersG JansenLoss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cellsJ Biol Chem27866806686200310.1074/jbc.M209186200

ME PeterP LegembreBC BarnhartDoes CD95 have tumor promoting activities?Biochim Biophys Acta17552536200515907590

S FuldaKM DebatinExtrinsic versus intrinsic apoptosis pathways in anticancer chemotherapyOncogene2547984811200610.1038/sj.onc.120960816892092

P FeiW WangSH KimS WangTF BurnsJK SaxM BuzzaiDT DickerWG McKennaEJ BernhardWS El-DeiryBnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growthCancer Cell6597609200410.1016/j.ccr.2004.10.01215607964

G van LooX SaelensM van GurpM MacFarlaneSJ MartinP VandenabeeleThe role of mitochondrial factors in apoptosis: a Russian roulette with more than one bulletCell Death Differ910311042200212232790

SA SusinHK LorenzoN ZamzamiI MarzoBE SnowGM BrothersJ MangionE JacototP CostantiniM LoefflerN LarochetteDR GoodlettR AebersoldDP SiderovskiJM PenningerG KroemerMolecular characterization of mitochondrial apoptosis-inducing factorNature397441446199910.1038/171359989411

JY KimJJ ChoJ HaJH ParkThe carboxy terminal C-tail of BNip3 is crucial in induction of mitochondrial permeability transition in isolated mitochondriaArch Biochem Biophys398147152200210.1006/abbi.2001.267311831844

S LoveApoptosis and brain ischemiaProg Neuropsych-ophermacol Biol Psychiatry27267282200310.1016/S0278-5846(03)00022-8

A BurlacuRegulation of apoptosis by Bcl-2 family proteinJ Cell Mol Med7249257200310.1111/j.1582-4934.2003.tb00225.x14594549

JC ReedMechanisms of apoptosisAm J Pathol15714151430200010.1016/S0002-9440(10)64779-7

S OhSD PiroozD NiZ ZhaoC LiangAnti-autophagic Bcl-2: not just an innocent bystanderAutophagy7231232201110.4161/auto.7.2.1419821099349

F D’AnselmiA CucinaPM BiavaS ProiettirP ColucciaL FratiM BizzarriZebrafish stem cell differentiation stage factors suppress Bcl-xL release and enhance 5-Fu-mediated apoptosis in colon cancer cellsCurr Pharm Biotechnol122612672011

H ZhangM Bosch-MarceLA ShimodaYS TanJH BaekJB WesleyFJ GonzalezGL SemenzaMitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxiaJ Biol Chem2831089210903200810.1074/jbc.M80010220018281291